MedTrace Logo

Comparison of AMG and EMG to Avoid Residual Paralysis After General Anesthesia

NCT02126852 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 214

Last updated 2016-04-28

No results posted yet for this study

Summary

This study evaluates three different neuromuscular monitoring devices (acceleromyography, one- or three-dimensional, and electromyography) with regard to their precision to detect residual paralysis after injection of neuromuscular blocking agents and recurrence of paralysis after administration of reversal agents in a clinical setting.

Conditions

  • Observation of Neuromuscular Block
  • Respiratory Paralysis
  • Anaesthesia

Interventions

DEVICE

Acceleromyography (AMG, one-dimensionally)

Neuromuscular monitoring

DEVICE

Acceleromyography (AMG, three-dimensionally)

Neuromuscular monitoring

DEVICE

Electromyography (EMG)

Neuromuscular monitoring

Sponsors & Collaborators

  • Technical University of Munich

    lead OTHER

Principal Investigators

  • Manfred Blobner, M.D. · Klinik für Anaesthesiologie, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Str. 22, 81675 München, Germany

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02126852 on ClinicalTrials.gov